期刊文献+

健胃愈疡胶囊联合“三联疗法”治疗幽门螺杆菌阳性老年人消化性溃疡 被引量:6

pylori-related peptic Effect of Jianwei yuyang capsule plus triad-therapy of western medicine on heficobacterulcer in elderly
原文传递
导出
摘要 目的探讨健胃愈疡胶囊治疗幽门螺杆菌(Hp)阳性老年人消化性溃疡的效果。方法选取80例Hp阳性,年龄在60岁以上的消化性溃疡患者,随机分为两组。治疗组给予中药健胃愈疡胶囊和“三联疗法”(奥美拉唑,阿莫西林,甲硝唑);对照组仅给予“三联疗法”,疗程均为4周。治疗结束后6周应用胃镜和活检染色对溃疡愈合率和Hp根除率进行分析,同时观察主要症状改善情况。结果治疗组和对照组患者溃疡愈合率分别为75%(30/40)和50%(20/40),差异有统计学意义(X^2=5.33,P〈0.05);患者Hp根除率分别为85%(34/40)和65%(26/40),差异有统计学意义(X^2=4.27,P〈0.05);治疗有效率分别为90%和68%,差异有统计学意义(X^2=6.05,P〈0.05)。结论中药健胃愈疡胶囊联合“三联疗法”是一种比较理想的治疗Hp阳性老年消化性溃疡的治疗方案。 Objective To observe the clinical effects of Jianwei yuyang capsule combined with triad-therapyof western medicine on helicobacter pylori-related peptic ulcer in elderly. Methods Eighty patients above 60 years with peptic ulcer infected with helicobacter pylori were divided into two groups by random, and were treated with Jianweiyuyang capsule combined with triad-therapy of western medicine or triad-therapy of western medicine for 4weeks. The endoscopy and biopsy staining were used to analyze the cure rate and the helicobacter pylori eradication rate at the 6th week after the end of the treatment, and the main symptom improvement were observed. Results In the treatment group,the cure rate,the helicobacter pylori eradication rate and total effective rate were significantly higher than control group. The two groups were significantly different ( P 〈 0.05 ). Conclusion Jianweiyuyang capsule combined with triad-therapy of western medicine was a more ideal treatment program for helicobacter pylori-related peptic ulcer in elderly.
出处 《中国基层医药》 CAS 2011年第21期2893-2894,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 消化性溃疡 健胃愈疡胶囊 幽门螺杆菌 奥美拉唑 阿莫西林 甲硝唑 Peptic ulcer Jianwei yuyang Capsule Helicobacter pylori Omeprazole Amoxicillin Metronidazole
  • 相关文献

参考文献15

二级参考文献97

共引文献250

同被引文献68

  • 1莫翠毅,杨维忠.奥美拉唑联合克拉霉素、阿莫西林治疗老年消化性溃疡35例[J].中国老年学杂志,2014,34(2):478-479. 被引量:36
  • 2刘记,程华敏.消化性溃疡幽门螺杆菌感染的治疗[J].中国医药,2007,2(7):447-447. 被引量:11
  • 3张哲君.川芎嗪配合三联疗法治疗老年人消化性溃疡[J].医药论坛杂志,2007,28(17):49-50. 被引量:2
  • 4Vitaplana VE,Bolanos AM,Montes CC,et al.Impact of a programto promote sequential therapy with paracetamol and omeprazole[J].Eur J Hosp Pharm,2012,19(2):45-53.
  • 5马丽群.质子泵抑制剂的研究和临床应用进展[J].内科,2006,26(5):355-357.
  • 6Chung IS, Kim BW. Peptic ulcer diseases in Korea . Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2012, 13(5):3-25.
  • 7Vitaplana VE, Bolanos AMI, Montes CC, et al. Impact of a program to promote sequential therapy with paracetamol and omeprazole . Eur J Hosp Pharm, 2012, 19(2): 45-53.
  • 8McNicholl AG, Linares PM, Nyssen OP, et al. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection . Alimentary Pharmacology AND Therapeutics, 2012, 36(5):414-425.
  • 9Hayato S, Hasegawa S, Hojo S. Dose- response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese . Eur J Clin Pharmacol, 2012, 68:579-588.
  • 10Bektas M, Sarac N, Cetinkaya H, et al. Effects of Heticobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells.Annals of Gastroenterology, 2012, 25(2):123-127.

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部